| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| PICARD MEDICAL Aktie jetzt für 0€ handeln | |||||
| 05.05. | Picard Medical prices $5 million stock offering at $0.30/share | 3 | Investing.com | ||
| 05.05. | Picard Medical platziert Aktienemission über 5 Millionen US-Dollar zu 0,30 US-Dollar je Aktie | 1 | Investing.com Deutsch | ||
| 05.05. | Picard Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 01.05. | Picard Medical, Inc. - S-1/A, General form for registration of securities | - | SEC Filings | ||
| 30.04. | Picard Medical, Inc.: Picard Medical / SynCardia Recognizes Banner Health as Global Leader and Supporter in the Advancement of Total Artificial Heart Technology | 2 | GlobeNewswire (USA) | ||
| 29.04. | Picard Medical, Inc.: Picard Medical / SynCardia Featured in Interview Series with The Mullings Group | 1 | GlobeNewswire (USA) | ||
| 27.04. | Picard Medical, Inc. - S-1, General form for registration of securities | 3 | SEC Filings | ||
| 22.04. | Picard Medical reports Q1 topline results | 2 | Seeking Alpha | ||
| 22.04. | Picard Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 17.04. | Picard Medical, Inc.: Picard Medical / SynCardia to Present Next Generation Total Artificial Heart Platform at ISHLT 2026 in Toronto | 1 | GlobeNewswire (USA) | ||
| 13.04. | Picard Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 02.04. | Picard Medical, Inc.: Picard Medical / SynCardia COO to Deliver Keynote at Venture Café Phoenix During Arizona Tech Week | 1 | GlobeNewswire (USA) | ||
| 01.04. | Picard Medical, Inc.: Picard Medical / SynCardia to Participate in Voice of the Patient Event During AZ Tech Week | 1 | GlobeNewswire (USA) | ||
| 30.03. | Picard Medical, Inc. - 10-K, Annual Report | - | SEC Filings | ||
| 27.03. | Picard Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 25.03. | Picard Medical reports FY results | 1 | Seeking Alpha | ||
| 25.03. | Picard Medical, Inc.: Picard Medical Reports Full Year 2025 Financial Results | 254 | GlobeNewswire (Europe) | TUCSON, Ariz., March 25, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company"), parent company of SynCardia Systems LLC, maker of the world's first total artificial heart... ► Artikel lesen | |
| 20.03. | BTV Spotlights: Picard Medical, Contango, GMG, 5E Advanced, Klondike Gold, Nevada Organic, Nine Mile, FireFox, & Intrepid Metals | 569 | Newsfile | Watch on FOX Business News Saturday, March 14 at 5:00 PM EST and via the links belowVancouver, British Columbia--(Newsfile Corp. - March 20, 2026) - Tune into BTV-Business Television and Discover... ► Artikel lesen | |
| 20.03. | Picard Medical, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 20.03. | Picard Medical, Inc.: Picard Medical / SynCardia to Present its Next-Generation Emperor Total Artificial Heart Technology at the American College of Cardiology's Annual Scientific Session | 1 | GlobeNewswire (USA) |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 5,190 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Receives Medicare Enrollment Approval for CNSide Diagnostic | HOUSTON, May 07, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals... ► Artikel lesen | |
| ORGANON | 11,315 | 0,00 % | Organon & Co.: Europäische Kommission erteilt Marktzulassung für POHERDY (Pertuzumab) von Henlius und Organon, das erste in Europa zugelassene Biosimilar zu PERJETA (Pertuzumab) | Shanghai Henlius Biotech, Inc. (2696.HK) und Organon (NYSE: OGN) gaben heute bekannt, dass die Europäische Kommission die Zulassung für POHERDY (Pertuzumab) 420 mg/14 ml Injektion zur intravenösen... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,720 | 0,00 % | Co-Diagnostics JV secures KSA facility lease deal; CODX rallies 16% premarket | ||
| SENSEONICS | 4,680 | -4,49 % | H.C. Wainwright cuts Senseonics stock price target on dilution | ||
| VIRIDIAN THERAPEUTICS | 14,400 | -2,04 % | XFRA 1S1: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILVIRIDIAN THERAPEUTICS... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 37,800 | +2,72 % | Inspire Medical Systems, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| EMBECTA | 2,902 | +2,15 % | Embecta stock rating held at Neutral by BTIG after investor meetings | ||
| VYOME | 1,990 | +1,02 % | Vyome: Positive Phase-2-Daten für Wundbehandlung bei Krebspatienten | ||
| PROCEPT BIOROBOTICS | 28,730 | +8,62 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| AXOGEN | 35,760 | +3,26 % | Axogen, Inc.: Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock | ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral... ► Artikel lesen | |
| TACTILE SYSTEMS TECHNOLOGY | 22,800 | +12,43 % | TACTILE SYSTEMS TECHNOLOGY INC - 8-K, Current Report | ||
| APYX MEDICAL | 3,480 | +4,82 % | Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System | CLEARWATER Fla., May 11, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the "Company" or "Apyx Medical"), the leader in surgical aesthetics products marketed and sold as Renuvion... ► Artikel lesen | |
| GLAUKOS | 116,00 | +1,75 % | Glaukos - GKOS: Pullback-Setup mit Unterstützung bei 130 USD! | Starkes Wachstum erwartet! Aber Achtung: Insider verkaufen Glaukos-Aktien (GKOS) im Wert von 4.2 Millionen USD! Glaukos (GKOS) - US3773221029 Rückblick: Aufgrund der stark überkauften Situation am US-Gesamtmarkt... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 0,597 | -1,29 % | Lexaria Bioscience Corp.: Lexaria Bioscience Releases Second Episode of Investor Video Series | CEO Rich Christopher Discusses Recently Announced Material Transfer Agreement Extension and 2026 Research Priorities KELOWNA, BC / ACCESS Newswire / May 7, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX)... ► Artikel lesen | |
| ITONIC | 0,304 | -2,38 % | iTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule | BEIJING, China, April 23, 2026 (GLOBE NEWSWIRE) -- iTonic Holdings Ltd (the "Company" or "ITOC"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other... ► Artikel lesen |